Quantcast
Home > Quotes > CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel) (CANF) Quote & Summary Data

CANF 
$1.2809
*  
0.0109
0.86%
Get CANF Alerts
*Delayed - data as of Dec. 14, 2018 10:23 ET  -  Find a broker to begin trading CANF now
Exchange:AMEX
Industry: Health Care
Community Rating:
View:    CANF Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

1 Year Target
8
Today's High / Low
$ 1.30 / $ 1.27
Share Volume
4,731
90 Day Avg. Daily Volume
114,116
Previous Close
$ 1.27
52 Week High / Low
$ 2.75 / $ 1.12
Market Cap
25,850,029
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.24

Intraday Chart

Shares Traded

Share Volume:
4,731
90 Day Avg. Daily Volume:
114,116

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.22

Trading Range

The current last sale of $1.2809 is 14.37% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 1.30 $ 2.75
 Low: $ 1.27 $ 1.12

Company Description (as filed with the SEC)

Our legal name is Can-Fite Bio Pharma Ltd. and our commercial name is "Can-Fite." We are a company limited by shares organized under the laws of the State of Israel. Our principal executive offices are located at 10 Bareket Street, Kiryat Matalon, Petah-Tikva 4951778 Israel. Our telephone number is +972 (3) 924-1114. We were founded on September 11, 1994 by Pnina Fishman, Ph.D., our Chief Executive Officer and a director, and Ilan Cohn, Ph.D., our Chairman of the Board of Directors, under the name Can-Fite Technologies Ltd. On January 7, 2001, we changed our name to Can-Fite Bio Pharma Ltd. We completed our initial public offering in Israel in October 2005 and our ordinary shares are traded on the TASE under the symbol "CFBI". On October 2, 2012, our ADSs began trading over the counter, or OTC, in the United States under the symbol "CANFY" and on November 19, 2013, our ADSs began trading on the NYSE American under the symbol "CANF.  ... More ...  


Risk Grade

Where does CANF fit in the risk graph?


Risk Grade Scale

Consensus Recommendation

Analyst Info